Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 8962623 Aminopyrazine compounds

Patent 8962623 was granted and assigned to Locus Pharmaceuticals on February, 2015 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

‌

Locus Pharmaceuticals

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

89626230

Patent Inventor Names

Rupa S. Shetty0

Younghee Lee0

Bin Liu0

Jinming Zou0

Kevin J. Moriarity0

Kristofer K. Moffett0

Martha J. Kelly0

Date of Patent

February 24, 2015

Patent Application Number

140019360

Date Filed

February 29, 2012

Patent Citations Received

‌

US Patent 11926616 Aminopyrazine diol compounds as PI3K-γ inhibitors

Patent Primary Examiner

‌

Bruck Kifle

Patent abstract

A compound of formula (I):

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 8962623 Aminopyrazine compounds

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API